Asitri Dashboard
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 17
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT00295230 | Effects of Volume Guarantee With Pressure Supported vs. Synchronized Intermittent Mandatory Ventilation in VLBW Infants | ||
NCT02617446 | The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure | ||
NCT03217825 | Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan | ||
NCT04706962 | TH1902 in Patients With Advanced Solid Tumors | ||
NCT00934362 | Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease | ||
NCT00578734 | Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old | ||
NCT04325035 | The Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock | ||
NCT00807235 | Feasibility Study of Aerosolized Surfaxin in the Prevention of Respiratory Distress Syndrome (RDS) in Premature Infants | ||
NCT02636868 | The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age | ||
NCT00215540 | SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants. | ||
NCT02528318 | Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA | ||
NCT00004500 | Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome | ||
NCT02074059 | Trial to Assess the Safety and Tolerability of Lucinactant for Inhalation in Premature Neonates | ||
NCT05975021 | A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C | ||
NCT04264156 | A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age | ||
NCT04389671 | The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19) | ||
NCT00215553 | KL₄Surfactant Treatment in Patients With ARDS |